1 Subjects: “...Clinical Trials as Topic...”

2 Subjects: “...Randomized Controlled Trials as Topic...”

3 Subjects: “...Clinical Trials as Topic...”

4 Subjects: “...Clinical Trials as Topic...”

5 “... SOE). One head-to-head trial comparing exenatide with liraglutide reported a slightly greater...”

6 “... SOE). One head-to-head trial comparing exenatide with liraglutide reported a slightly greater...”

7 “... trials support greater efficacy with the addition of a LABA to an ICS than with a higher dose ICS (high...”

8 “... trials support greater efficacy with the addition of a LABA to an ICS than with a higher dose ICS (high...”

9 Subjects: “...Clinical Trials as Topic...”

10 “... in 1 trial for gabapentin, in 1 of 3 trials for cyclobenzaprine, and in 1 trial of fluoxetine...”

11 “... in 1 trial for gabapentin, in 1 of 3 trials for cyclobenzaprine, and in 1 trial of fluoxetine...”

12 “... SC (Rebif(r)) or interferon beta-1b (Betaseron(r)) based on 2 head-to-head trials. Evidence...”

13 “... SC (Rebif(r)) or interferon beta-1b (Betaseron(r)) based on 2 head-to-head trials. Evidence...”

14 “...RESULTS AND CONCLUSIONS: Although we identified 10 head-to-head trials comparing 2 or more long...”

15 “... on three head-to-head trials, several large observational studies, and indirect comparisons of placebo...”

16 “...RESULTS AND CONCLUSIONS: Although we identified 10 head-to-head trials comparing 2 or more long...”

17 “... on three head-to-head trials, several large observational studies, and indirect comparisons of placebo...”

18 “.... DATA SOURCES: To identify published studies, we searched MEDLINE, Cochrane Central Register...”

19

20